Ozempic Is a Hit. So Why Is the Drugmaker’s C...

Stock markets are hitting record highs, the job market is doing fine and productivity is up. Yet many Americans are feeling strapped despite the positive data. WSJ’s Harriet Torry explains the contradictory signals. Jessica Mendoza hosts. Further Listening: - The Energy Shock Is ...  Afficher plus

The initial public offering for SpaceX crowned Elon Musk the world’s first trillionaire. WSJ’s Theo Francis takes us inside the staggering finances of the world’s richest man, and explores what the impact of his new status might be. Jessica Mendoza hosts. Further Listening: - Is ...  Afficher plus

President Trump struck a deal with Big Pharma for $150 GLP-1 drugs… a total euro move.On the 10th anniversary of the Baby Shark video… its owner PinkFong IPO’d at a $400 million valuation.Lyft’s CEO celebrated their best quarter yet… by joining The Best One Yet in-studioLooksMapp ...  Afficher plus

It’s been a turbulent fortnight for corporate leadership, with sudden CEO exits at companies like HUL, Coca Cola bottler HCCB, L’Oréal, Diageo, Kenvue and WPP. In this episode of The Morning Brief, host Ratna Bhushan speaks to ET’s Associate Editor Arijit Barman and Vibhav Dhawan ...  Afficher plus

Episode 414: Neal and Toby break down with Nike CEO John Donahoe announces he is retiring after the company's struggling sales. Plus, the guys explain why every single board member resigned from 23andMe this week. Then, Olive Garden cuts a deal with Uber to deliver bread sticks a ...  Afficher plus

Fresh news on the tariff front when it comes to potential deals – and hopes of relief for the automakers… Carl Quintanilla, Sara Eisen, and David Faber broke down the latest from the White House, alongside the morning’s biggest earnings stories: from GM pulling guidance and de ...